Hypertension 英/haɪpə'tenʃ(ə)n/ 美/,haɪpɚ'tɛnʃən/
释 义 a common disorder in which blood pressure remains abnormally high (a reading of 140/90 mm Hg or greater) n. 高血压；过度紧张
同根词 hypertrophy n.[病理] 肥大；过度增大；hypersomnia n.嗜睡，[医] 睡眠过度
例 句 Hypertension and high cholesterol can be controlled.
作者： Bryan Williams
期刊：Eur. Heart J.
Hypertension is defined as office SBP values ≥140 mmHg and/or diastolic BP (DBP) values≥90 mmHg. This is based on evidence from multiple RCTs that treatment of patients with these BP values is beneficial. The same classification is used in younger, middle aged, and older people, whereas BP centiles are used in children and teenagers, in whom data from interventional trials are not available. Details on BP classification in boys and girls ≤16 years of age can be found in the 2016 ESH Guidelines for children and adolescents. Based on office BP, the global prevalence of hypertension was estimated to be 1.13 billion in 2015, with a prevalence of over 150 million in central and eastern Europe. The overall prevalence of hypertension in adults is around 30 - 45%, with a global age standardized prevalence of 24 and 20% in men and women, respectively, in 2015. This high prevalence of hypertension is consistent across the world, irrespective of income status, i.e. in lower, middle, and higher income countries. Hypertension becomes progressively more common with advancing age, with a prevalence of >60% in people aged >60 years. As populations age, adopt more sedentary lifestyles, and increase their body weight, the prevalence of hypertension worldwide will continue to rise. Elevated BP was the leading global contributor to premature death in 2015, accounting for almost 10 million deaths and over 200 million disability-adjusted life years.3 Importantly, despite advances in diagnosis and treatment over the past 30 years, the disability-adjusted life years attributable to hypertension have increased by 40% since 1990. SBP ≥140 mmHg accounts for most of the mortality and disability burden (70%), and the largest number of SBP-related deaths per year are due to ischaemic heart disease (4.9 million), haemorrhagic stroke (2.0 million), and ischaemic stroke (1.5 million).